Stay updated on Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.
Latest updates to the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check11 days agoChange DetectedThe website has updated the intervention details to include a verified status from February 2020 and has revised to version 2.14.0, while the previous version 2.13.3 and its intervention type have been removed.SummaryDifference4%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check40 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check47 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has removed a detailed section regarding data download options and fields related to clinical studies, which may impact users looking for specific study information.SummaryDifference13%
- Check68 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
Stay in the know with updates to Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.